Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Sullivan

Showing results (101-110 of 184) with videos related to

Pageof 19
Sort By:
Heart, Lung & Circulation|December 20, 2005
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005Andrew Tonkin, Philip Barter, James Best, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 13, 2012
Early rapid identification of in vivo rat metabolites of AN6414, a novel boron-containing PDE4 inhibitor by QTRAP LC/MS/MS to support drug discoveryWei Bu, Tsutomu Akama, Sanjay Chanda, et al.
Nature Medicine|May 17, 2011
Host-mediated regulation of superinfection in malariaSilvia Portugal, Céline Carret, Mario Recker, et al.
Cardiology and Therapy|June 22, 2020
A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 StudiesMichael J Koren, Peter H Jones, Jennifer G Robinson, et al.
International Journal of Cardiology|February 11, 2014
Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID studyAnne Funke-Kaiser, Kristy Mann, David Colquhoun, et al.
European Journal of Medicinal Chemistry|August 23, 2014
Highly potent anti-proliferative effects of a gallium(III) complex with 7-chloroquinoline thiosemicarbazone as a ligand: synthesis, cytotoxic and antimalarial evaluationKewal Kumar, Sarah Schniper, Antonio González-Sarrías, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Rapid On-Demand Point-of-Care Monitoring of Clozapine and Its Metabolite Norclozapine Using Miniature Mass SpectrometryXiaosuo Wang, Wei Yi Lew, Yang Yang, et al.
Therapeutic Advances in Medical Oncology|December 18, 2024
Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapyRhiannon Mellor, Luke Ardolino, Tahlia Scheinberg, et al.
Frontiers in Pharmacology|March 25, 2022
Prior Cardiovascular Treatments-A Key Characteristic in Determining Medication Adherence After an Acute Myocardial InfarctionAnna Campain, Carinna Hockham, Louisa Sukkar, et al.
Journal of Medicinal Chemistry|December 2, 2011
Malaria-infected mice are completely cured by one 6 mg/kg oral dose of a new monomeric trioxane sulfide combined with mefloquineRachel D Slack, Bryan T Mott, Lauren E Woodard, et al.
Pageof 19

Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
Heart, Lung & Circulation|December 20, 2005
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005Andrew Tonkin, Philip Barter, James Best, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 13, 2012
Early rapid identification of in vivo rat metabolites of AN6414, a novel boron-containing PDE4 inhibitor by QTRAP LC/MS/MS to support drug discoveryWei Bu, Tsutomu Akama, Sanjay Chanda, et al.
Nature Medicine|May 17, 2011
Host-mediated regulation of superinfection in malariaSilvia Portugal, Céline Carret, Mario Recker, et al.
Cardiology and Therapy|June 22, 2020
A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 StudiesMichael J Koren, Peter H Jones, Jennifer G Robinson, et al.
International Journal of Cardiology|February 11, 2014
Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID studyAnne Funke-Kaiser, Kristy Mann, David Colquhoun, et al.
European Journal of Medicinal Chemistry|August 23, 2014
Highly potent anti-proliferative effects of a gallium(III) complex with 7-chloroquinoline thiosemicarbazone as a ligand: synthesis, cytotoxic and antimalarial evaluationKewal Kumar, Sarah Schniper, Antonio González-Sarrías, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Rapid On-Demand Point-of-Care Monitoring of Clozapine and Its Metabolite Norclozapine Using Miniature Mass SpectrometryXiaosuo Wang, Wei Yi Lew, Yang Yang, et al.
Therapeutic Advances in Medical Oncology|December 18, 2024
Evolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapyRhiannon Mellor, Luke Ardolino, Tahlia Scheinberg, et al.
Frontiers in Pharmacology|March 25, 2022
Prior Cardiovascular Treatments-A Key Characteristic in Determining Medication Adherence After an Acute Myocardial InfarctionAnna Campain, Carinna Hockham, Louisa Sukkar, et al.
Journal of Medicinal Chemistry|December 2, 2011
Malaria-infected mice are completely cured by one 6 mg/kg oral dose of a new monomeric trioxane sulfide combined with mefloquineRachel D Slack, Bryan T Mott, Lauren E Woodard, et al.
Pageof 19